Skip to main content
Grant Details

Grant Number: 5R01CA189184-04 Interpret this number
Primary Investigator: Li, Christopher
Organization: Fred Hutchinson Cancer Research Center
Project Title: Discovery and Verification of Novel Biomarkers of Colorectal Cancer Recurrence
Fiscal Year: 2018
Back to top


Abstract

? DESCRIPTION (provided by applicant): In order to realize the promise of precision medicine, more and better biomarkers are needed to guide clinical decision making. This is of particular importance for patients with colorectal cancer (CRC) as: 1. CRC is the third most common cancer in both men and women accounting for 9% of all incident cancers in the United States; 2. The 5-year survival rates for the most common cancers in men and women, prostate and breast cancer, are 99% and 89%, respectively, but is only 64% for CRC making it the second most common cause of cancer related death in the U.S.; 3. At present there is a lack of clinically useful biomarkers predictive of recurrence or survival for CRC patients that can be used to guide surveillance and treatment. Consequently, there are issues of both overtreatment and undertreatment because treatment is based largely on clinical and pathologic parameters, but little else to risk stratify patients. This study will utilize 1,574 participants in a multi- cente prospective cohort (the ColoCare Study) of newly diagnosed CRC patients. Detailed demographic, clinical, epidemiologic, and follow-up data are ascertained on all participants along with blood samples collected at multiple time points. Thus, this study is specifically designed to meet the overarching goal of this proposal, the discovery and verification of novel blood-based biomarkers predictive of recurrence among CRC patients, through achieving the following specific aims: 1. Discovery and verification of novel biomarkers predictive of recurrence among CRC patients: Utilizing samples collected at the time of diagnosis we will evaluate the plasma proteome, glycome, and autoantibody repertoire, including assessment of promising markers reported in the literature, using well-validated laboratory approaches to identify markers predictive of risk of recurrence for well-defined clinical applications (predictin recurrence in stage I/II patients and in stage III patients). Top candidates from our discovery experiments meeting particular statistical criteria will be evaluated in a group of patients completely separate from those used in the discovery set. 2. Discovery and verification of novel biomarkers useful for the early detection of CRC recurrence: Utilizing serial samples collected at regular intervals post-diagnosis we will discover novel biomarkers potentially useful for disease monitoring using proteomic, glycomic, and autoantibody platforms. Markers will be evaluated in the context of CEA, a clinically used biomarker of recurrence that has a 60% sensitivity and 90% specificity for detecting recurrent colorectal cancer in stage II and III patients. If successfl this project could lead to the development of clinical grade biomarker assays that could have significant impact on reducing the morbidity and mortality associated with colorectal cancer. This study is innovative in that the cohort that will be used is unique, highly characterized, and possesses serial samples collected at regular intervals; the unique platforms that will be used have been shown to yield potentially useful biomarkers and can also evaluate existing markers of interest; and this study is powered to identify biomarkers with clinically meaningful performance characteristics.

Back to top


Publications

Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study.
Authors: Himbert C. , Ose J. , Nattenmüller J. , Warby C.A. , Holowatyj A.N. , Böhm J. , Lin T. , Haffa M. , Gigic B. , Hardikar S. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2018-10-17 00:00:00.0; , .
EPub date: 2018-10-17 00:00:00.0.
PMID: 30333223
Related Citations

Rare loss of function variants in candidate genes and risk of colorectal cancer.
Authors: Rosenthal E.A. , Shirts B.H. , Amendola L.M. , Horike-Pyne M. , Robertson P.D. , Hisama F.M. , Bennett R.L. , Dorschner M.O. , Nickerson D.A. , Stanaway I.B. , et al. .
Source: Human Genetics, 2018-09-28 00:00:00.0; , .
EPub date: 2018-09-28 00:00:00.0.
PMID: 30267214
Related Citations

Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer.
Authors: Neumeyer S. , Banbury B.L. , Arndt V. , Berndt S.I. , Bezieau S. , Bien S.A. , Buchanan D.D. , Butterbach K. , Caan B.J. , Campbell P.T. , et al. .
Source: British Journal Of Cancer, 2018 Jun; 118(12), p. 1639-1647.
EPub date: 2018-05-24 00:00:00.0.
PMID: 29795306
Related Citations

Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.
Authors: Delphan M. , Lin T. , Liesenfeld D.B. , Nattenmüller J. , Böhm J.T. , Gigic B. , Habermann N. , Zielske L. , Schrotz-King P. , Schneider M. , et al. .
Source: Metabolomics : Official Journal Of The Metabolomic Society, 2018 Mar; 2018(14), .
EPub date: 2018-01-31 00:00:00.0.
PMID: 29706852
Related Citations

Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study.
Authors: Gigic B. , Boeing H. , Toth R. , Böhm J. , Habermann N. , Scherer D. , Schrotz-King P. , Abbenhardt-Martin C. , Skender S. , Brenner H. , et al. .
Source: Nutrition And Cancer, 2018 Jan; 70(1), p. 51-60.
EPub date: 2017-12-15 00:00:00.0.
PMID: 29244538
Related Citations

Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
Authors: Sheth H. , Northwood E. , Ulrich C.M. , Scherer D. , Elliott F. , Barrett J.H. , Forman D. , Wolf C.R. , Smith G. , Jackson M.S. , et al. .
Source: Plos One, 2018; 13(2), p. e0192223.
EPub date: 2018-02-09 00:00:00.0.
PMID: 29425227
Related Citations

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
Authors: Barault L. , Amatu A. , Siravegna G. , Ponzetti A. , Moran S. , Cassingena A. , Mussolin B. , Falcomatà C. , Binder A.M. , Cristiano C. , et al. .
Source: Gut, 2017-10-05 00:00:00.0; , .
EPub date: 2017-10-05 00:00:00.0.
PMID: 28982739
Related Citations

Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.
Authors: Himbert C. , Delphan M. , Scherer D. , Bowers L.W. , Hursting S. , Ulrich C.M. .
Source: Cancer Prevention Research (philadelphia, Pa.), 2017 Sep; 10(9), p. 494-506.
PMID: 28864539
Related Citations

Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.
Authors: Barrow T.M. , Klett H. , Toth R. , Böhm J. , Gigic B. , Habermann N. , Scherer D. , Schrotz-King P. , Skender S. , Abbenhardt-Martin C. , et al. .
Source: The Journal Of Pathology, 2017-08-09 00:00:00.0; , .
EPub date: 2017-08-09 00:00:00.0.
PMID: 28791728
Related Citations

Effects of Intentional Weight Loss on Markers of Oxidative Stress, DNA Repair and Telomere Length - a Systematic Review.
Authors: Himbert C. , Thompson H. , Ulrich C.M. .
Source: Obesity Facts, 2017; 10(6), p. 648-665.
EPub date: 2017-12-14 00:00:00.0.
PMID: 29237161
Related Citations

Discovery Of Novel Plasma Proteins As Biomarkers For The Development Of Incisional Hernias After Midline Incision In Patients With Colorectal Cancer: The Colocare Study
Authors: Böhm J. , Pianka F. , Stüttgen N. , Rho J. , Gigic B. , Zhang Y. , Habermann N. , Schrotz-King P. , Abbenhardt-Martin C. , Zielske L. , et al. .
Source: Surgery, 2016-10-13 00:00:00.0; , .
PMID: 27745870
Related Citations




Back to Top